Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood eosinophil-guided systemic steroid treatment for nasal polyps
ChiCTR1800014933Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prednisolone in chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinosinusitis (CRS) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Endoscopic polyps score. Started Mar 2018; status: recruiting.
02
Drugs
prednisolone
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ChiCTR1800014933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014933.